EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation

Javier Negueruela, Valerie Vandenbempt, Stephanie Talamantes, Francisco Ribeiro-Costa, Mariana Nunes, André Dias, Mayank Bansal, Esteban N Gurzov

STAR Protocols · 2024

DOI: 10.1016/j.xpro.2024.103297 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift STAR Protocols, 2024. Verfasst von Javier Negueruela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: …. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Pluripotent Stem Cells, Insulin-Secreting Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, JDRF, Helsingin Yliopisto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene editing of human pluripotent stem cells is a promising approach for developing targeted gene therapies for metabolic diseases. Here, we present a protocol for generating a CRISPR-Cas12a gene knockout of protein tyrosine phosphatases in human embryonic stem cells. We describe steps for differentiating the edited clones into pancreatic islet-like spheroids rich in β-like cells. We then detail procedures for implanting these spheroids under the murine kidney capsule for in vivo maturation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsPluripotent Stem CellsInsulin-Secreting CellsProtein Tyrosine PhosphatasesHumansMiceAnimalsCell DifferentiationHuman Embryonic Stem Cells

Stichwörter der Autor:innen

CRISPRCell DifferentiationMetabolismModel OrganismsMolecular BiologyProtein BiochemistryStem Cells

Substanzen

Protein Tyrosine Phosphatases

Autor:innen und Institutionen

  • Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: javier.negueruela.escudero@ulb.be.
  • Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium.
  • Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: mayank.bansal@ulb.be.
  • Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Anderlecht, 1070 Brussels-Capital Region, Belgium. Electronic address: esteban.gurzov@ulb.be.

Förderung

  • European Research Council
  • JDRF
  • Helsingin Yliopisto
  • Juvenile Diabetes Research Foundation United States of America
  • FRS-FNRS

Zitieren

APA

Negueruela, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols. https://doi.org/10.1016/j.xpro.2024.103297

Vancouver

Negueruela J, Vandenbempt V, Talamantes S, Ribeiro-Costa F, Nunes M, Dias A, et al. Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols. 2024. doi:10.1016/j.xpro.2024.103297

BibTeX
@article{Negueruela2024,
  author = {Negueruela, Javier and Vandenbempt, Valerie and Talamantes, Stephanie and Ribeiro-Costa, Francisco and Nunes, Mariana and Dias, André and Bansal, Mayank and Gurzov, Esteban N},
  title = {Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation},
  journal = {STAR Protocols},
  year = {2024},
  doi = {10.1016/j.xpro.2024.103297}
}
Kostenlos starten →